Amgen is a biotechnology company with a focus on innovative human medicines. It focuses on six treatment areas ­- cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. Some of its prominent products include Aimovig, Aranesp, Corlanor, Enbrel, Epogen, Evenity, Kanjiniti, Kyprolis, Mvasi, Nplate, Otezla, and Parsabiv. The company’s research and development (R&D) activity focuses on novel human drugs for the treatment of serious illnesses. It uses science and technology to study subtle biological mechanisms in search of therapies. It pursues a biology-first approach in which its scientists first explore the complex molecular pathways of disease before deciding on the type of medicine or modality required to deliver optimal efficacy and safety. Its subsidiary, deCODE Genetics, has emerged as a major player in human genetics, helping Amgen in identifying and validating human disease targets.